A TNFα/Miz1-positive feedback loop inhibits mitophagy in hepatocytes and propagates nonalcoholic steatohepatitis

Kangpeng Jin,Yuze Shi,Haitian Zhang,Guangyan Zhangyuan,Fei Wang,Shuo Li,Chen Chen,Jinyao Zhang,Hua Wang,Wenjie Zhang,Beicheng Sun

DOI: https://doi.org/10.1016/j.jhep.2023.03.039

IF: 25.7

2023-04-11

Journal of Hepatology

Abstract:Background & Aims NASH is a chronic inflammatory disease that further progresses to cirrhosis and HCC. However, the key molecular mechanism of this process has not been clarified. Methods We analyzed human NASH and normal liver tissue samples by RNA-Seq and LS/MS and identified hepatocyte cytosolic protein Myc-interacting zinc-finger protein 1 (Miz1) as a potential target in NASH progression. We established a Western diet with fructose-induced NASH model in hepatocyte-specific Miz1 knockout and AVV8-overexpressing mice. Human NASH liver organoids were used to confirm the mechanism, and IP/LS/MS were used to detect proteins that can interact with Miz1. Results We demonstrate that Miz1 is reduced in hepatocytes in human NASH. Miz1 is shown to bind to peroxiredoxin 6 (PRDX6), retaining it in the cytosol and blocking PRDX6 from interacting with mitochondrial Parkin at Cys431 and inhibiting Parkin-mediated mitophagy. In NASH livers loss of hepatocyte Miz1 results in PRDX6-mediated inhibition of mitophagy, increased dysfunctional mitochondria in hepatocytes, and production of proinflammatory cytokines, including TNFα, by hepatic macrophages. Crucially, the increased production of TNFα results in a further reduction in hepatocyte Miz1 by E3-ubiquitination. This produces a positive feedback loop of TNFα-mediated hepatocyte Miz1 degradation, resulting in PRDX6-mediated inhibition of hepatocyte mitophagy, with the accumulation of dysfunctional hepatocyte mitochondria and increased macrophage TNFα production. Conclusions Our study identified hepatocyte Miz1 as a suppressor of NASH progression and a positive feedback loop of macrophage TNFα-induced degradation of the cytosolic hepatocyte protein Miz1, which results in reduced hepatocyte mitophagy, increased damaged mitochondria and increased TNFα production. Interruption of this positive feedback loop can inhibit the progression of NASH. Impact and implication NASH is a chronic inflammatory disease that can further develop into cirrhosis and HCC. However, the key molecular mechanism of this process has not been fully clarified. Herein, we identified a positive feedback loop of macrophage TNF α -mediated hepatocyte Miz1 degradation, resulting in PRDX6-mediated inhibition of hepatocyte mitophagy, aggravation of mitochondrial damage and increase in macrophage TNF α production. Our findings not only provide mechanistic insight into NASH progression but also provide potential therapeutic targets for NASH patients. Our human NASH liver organoid culture is therefore a useful platform for exploring treatment strategies for NASH development.

gastroenterology & hepatology